Avastin Proves Drug Rationing Alive And Well

During the health care debate, few charges were more controversial than the one that government would decide who lives and who dies by rationing medical care. But based on a recent government health care ruling, it looks as if that accusation wasn't such an exaggeration. In late December, the Food and Drug Administration moved to rescind the approval of a miracle drug that currently represents the last, best hope for women with metastatic breast cancer. Each year 17,500 women are treated with Avastin, a late-stage breast cancer drug that restricts blood flow to tumors, slowing their growth, shrinking them, sometimes...